Status:

COMPLETED

A Study in Healthy Male Subjects to Investigate the Effect of Famotidine and Efavirenz on the Way the Body Takes up, Distributes, and Gets Rid of Daridorexant.

Lead Sponsor:

Idorsia Pharmaceuticals Ltd.

Conditions:

Healthy

Eligibility:

MALE

18-45 years

Phase:

PHASE1

Brief Summary

A study in healthy male subjects to investigate the effect of famotidine and efavirenz on the way the body takes up, distributes, and gets rid of daridorexant.

Eligibility Criteria

Inclusion

  • Signed informed consent in a language understandable to the subject prior to any study-mandated procedure.
  • Healthy male subjects aged between 18 and 45 years (inclusive) at Screening.

Exclusion

  • Clinically relevant findings on the physical examination at Screening.
  • Clinically relevant abnormalities on 12-lead ECG, measured after at least 5 min in a supine position at Screening.
  • Clinically relevant findings in clinical laboratory tests (hematology, clinical chemistry) at Screening and on Day -1.
  • History of major medical or surgical disorders which, in the opinion of the investigator, are likely to interfere with the absorption, distribution, metabolism, or excretion of the study treatment(s) (appendectomy and herniotomy allowed, cholecystectomy not allowed).
  • Any circumstances or conditions, which, in the opinion of the investigator, may affect full participation in the study or compliance with the protocol.
  • Moderate or severe renal insufficiency (creatinine clearance \< 60 mL/min calculated with the Cockcroft Gault formula) at Screening.
  • Total bilirubin \> 1.5 x Upper Limit of Normal at Screening.

Key Trial Info

Start Date :

May 13 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 26 2020

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT04390334

Start Date

May 13 2020

End Date

June 26 2020

Last Update

September 16 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CRS Clinical Research Services Mannheim GmbH

Mannheim, Germany, 68167